Literature DB >> 6574466

Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures.

P B Fisher, A F Miranda, L E Babiss, S Pestka, I B Weinstein.   

Abstract

We have studied the effects of human leukocyte interferon produced in bacteria and diterpene phorbol ester tumor promoters on differentiation of normal human myoblast cultures derived from mature skeletal muscle. Interferon (100-5,000 units/ml) induced an acceleration of myotube formation and creatine kinase (CK; EC 2.7.3.2) isoenzyme transition from CK-BB to CK-MM. Heat-inactivated or trypsin-treated interferon did not affect the differentiation process. In contrast, the potent tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA), but not its inactive structural analogues phorbol and 4 alpha-phorbol 12,13-didecanoate, caused a dose-dependent (0.01-100 ng/ml) inhibition of myotube formation and CK isoenzyme transition. Neither interferon nor TPA had a significant effect on myoblast proliferation prior to fusion, and the cloning efficiencies were similar as well. Opposing effects of interferon and TPA were also demonstrated by simultaneous application of these agents to the cultures. These studies suggest that some of the antitumor effects of interferon may relate to its capacity to modulate cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6574466      PMCID: PMC393953          DOI: 10.1073/pnas.80.10.2961

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Antiviral and cell growth inhibitory activities reside in the same glycoprotein of human fibroblast interferon.

Authors:  E Knight
Journal:  Nature       Date:  1976-07-22       Impact factor: 49.962

2.  Inhibition of transcription and translation of globin messenger RNA in dimethyl sulfoxide-stimulated Friend erythroleukemic cells treated with interferon.

Authors:  G B Rossi; A Dolei; L Cioé; A Benedetto; G P Matarese; F Belardelli
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

3.  Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture.

Authors:  G Rovera; T G O'Brien; L Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

4.  An improved procedure for serum creatine phosphokinase determination.

Authors:  S B Rosalki
Journal:  J Lab Clin Med       Date:  1967-04

5.  Control of myogenesis in vitro by Ca 2 + concentration in nutritional medium.

Authors:  A Shainberg; G Yagil; D Yaffe
Journal:  Exp Cell Res       Date:  1969-11       Impact factor: 3.905

6.  The in vitro cultivation and differentiation capacities of myogenic cell lines.

Authors:  C Richler; D Yaffe
Journal:  Dev Biol       Date:  1970-09       Impact factor: 3.582

7.  Interferon inhibits dimethyl sulphoxide-induced erythroid differentiation of Friend leukaemia cells.

Authors:  G B Rossi; G P Matarese; C Grappelli; F Belardelli; A Benedetto
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

8.  Effect of a tumour promoter on myogenesis.

Authors:  R Cohen; M Pacifici; N Rubinstein; J Biehl; H Holtzer
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

9.  Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters.

Authors:  L Diamond; T G O'Brien; G Rovera
Journal:  Nature       Date:  1977-09-15       Impact factor: 49.962

10.  Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture.

Authors:  H Yamasaki; E Fibach; U Nudel; I B Weinstein; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

View more
  12 in total

1.  The effect of interferons on cellular differentiation.

Authors:  T Moritz; H Kirchner
Journal:  Blut       Date:  1986-11

2.  IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation.

Authors:  S Armando Villalta; Bo Deng; Chiara Rinaldi; Michelle Wehling-Henricks; James G Tidball
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

Review 3.  Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.

Authors:  Paola M Barral; Devanand Sarkar; Zao-zhong Su; Glen N Barber; Rob DeSalle; Vincent R Racaniello; Paul B Fisher
Journal:  Pharmacol Ther       Date:  2009-07-15       Impact factor: 12.310

Review 4.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

Review 5.  Shared signaling systems in myeloid cell-mediated muscle regeneration.

Authors:  James G Tidball; Kenneth Dorshkind; Michelle Wehling-Henricks
Journal:  Development       Date:  2014-03       Impact factor: 6.868

6.  Interferons modulate the expression of hormone receptors on the surface of murine melanoma cells.

Authors:  K Kameyama; S Tanaka; Y Ishida; V J Hearing
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

Review 7.  The fusion of myoblasts.

Authors:  M J Wakelam
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

8.  Isolation and clonal analysis of satellite cells from chicken pectoralis muscle.

Authors:  Z Yablonka-Reuveni; L S Quinn; M Nameroff
Journal:  Dev Biol       Date:  1987-01       Impact factor: 3.582

9.  Increase in p202 expression during skeletal muscle differentiation: inhibition of MyoD protein expression and activity by p202.

Authors:  B Datta; W Min; S Burma; P Lengyel
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

10.  The 2'-5' oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation.

Authors:  C Bisbal; M Silhol; H Laubenthal; T Kaluza; G Carnac; L Milligan; F Le Roy; T Salehzada
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.